Do you or someone you care about have MS? MS PathwaysSM is the source for personalized support for BETASERON patients and those considering BETASERON therapy. Take advantage of the many helpful tools offered by MS PathwaysSM, including Injection Reminders to help you stay on your treatment schedule.
Get a printable doctor-patient discussion guide to help prepare you for speaking with your healthcare professional about choosing a disease-modifying therapy.
MS Resource Center
Welcome to the MS Resource Center. If you, a friend, or a family member is living with multiple sclerosis (MS), the MS Resource Center is your place for information and education. Learning all you can about MS—its symptoms, causes, and management—can better prepare you to care for yourself or a loved one with MS.
The challenges of having MS may involve many issues including your medication. Side effects, self-injection matters, and cost may be among the several concerns you face with your disease-modifying therapy. These challenges are not insurmountable.
Thanks to advances in treatment, wellness techniques, and the latest news and clinical findings, many people living with MS can live full and productive lives. Our selection of Educational Brochures can help you better understand MS and its treatment. The brochures are easy to read and quick to print, so you can share what you find with your loved ones and your healthcare team.
Remember, the more you learn about MS, the more control you have over your condition.
BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
